T 1525/10 (Sustained release of fluvastatin/NOVARTIS AG) of 20.09.2011
- European Case Law Identifier
- ECLI:EP:BA:2011:T152510.20110920
- Date of decision
- 20 September 2011
- Case number
- T 1525/10
- Petition for review of
- -
- Application number
- 97944240.7
- IPC class
- A61K 9/20A61K 31/19
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Pharmaceutical compositions for sustained release of the HMG-CoA reductase inhibitor fluvastatin
- Applicant name
- Novartis AG
Novartis Pharma GmbH - Opponent name
- Ratiopharm GmbH
Actavis UK Ltd
Actavis GmbH
Mylan S.A.S. - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 84Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Main request and auxiliary request I - clarity (no): parameter and method for measuring it not clearly defined
Auxiliary request I - Article 123(2) EPC (no): unallowable generalisation
Auxiliary request II - admission (no): request withdrawn in first instance proceedings - Catchword
- -
ORDER
For these reasons it is decided that:
The appeal is dismissed.